Nimes, France // Halle (Saale), Germany // Companies to apply Pep:trans technology to vectorise product into the brain to treat Multiple Sclerosis. probiodrug AG, a German […]
Halle (Saale), Germany // Probiodrug AG announced today that under the first phase of its licensing program, it has granted Ferring BV and its sublicensee, Ortho-McNeil […]
Halle (Saale), Germany // Merck & Co., Inc., Whitehouse Station, NJ, USA and probiodrug Gesellschaft für Arzneimittelforschung mbH, Halle (Saale), Germany announced today that they have […]
Halle (Saale), Germany // Die im Biozentrum in Halle (Saale) geschäftsansässige Probiodrug Gesellschaft für Arzneimittelforschung mbH hat im Oktober 2000 eine 3. Finanzierungsrunde mit der Einwerbung […]
Halle (Saale), Germany // Probiodrug closed a private investment, effective January 1st, 2000, summing up to DM 14 million. The capital was invested mainly by the […]
Halle (Saale), Germany // Probiodrug concludes preclinical development of P32/98. P32/98 is a potent orally available inhibitor of dipeptidyl peptidase IV (DP IV). The proteolytic enzyme […]
Professors Raymond Pederson and Christopher McIntosh, Physiology Department, University of British Columbia – collaborators and scientific advisors to probiodrug research GmbH, Halle (Saale), Germany Vancouver, Canada […]
During a presentation at the IBC-conference on Obesity & Non-Insulin Dependent Diabetes Mellitus held at the Royal College of Pathologists, Dr. H.-U. Demuth, CRO of probiodrug […]